Table 3. Association between serum anti-EID3 Abs positive rate and the clinicopathological features of NF-pNET patients.

Characteristic		Cases	anti-EID3 Abs positive rate	p value
		n	n (%)
Gender	Male	9	3 (33)	0.6913
	Female	16	7 (44)
Age	<54	12	6 (50)	0.4283
	≥54	13	4 (31)
Tumor size	<17 mm	12	5 (41)	>0.9999
	≥17 mm	13	5 (38)
Grade	G1	8	4 (50)	0.6668
	G2	17	6 (35)
Ki-67/MIB-1	<3%	11	6 (54)	0.2406
	3–20%	14	4 (28)
T	T1, T2	20	6 (30)	0.1206
	T3, T4	5	4 (80)
N	N0	16	5 (31)	0.3973
	N1	9	5 (55)
M	M0	19	7 (37)	0.6532
	M1	6	3 (50)
Stage	I, II	14	4 (29)	0.2406
	III, IV	11	6 (54)

NF-pNET: non-functional pancreatic neuroendocrine tumor, Abs: antibodies